Nutra Pharma Corp. (NPHC)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jun 27, 2025, 10:45 AM EDT
0.00%
Market Cap 709.97K
Revenue (ttm) 247.77K
Net Income (ttm) 7.11M
Shares Out 7.10B
EPS (ttm) 0.00
PE Ratio 0.20
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 32,626
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range n/a
Beta 30.62
RSI 36.40
Earnings Date n/a

About Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain as... [Read more]

Sector Healthcare
Founded 2000
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol NPHC
Full Company Profile

Financial Performance

In 2021, Nutra Pharma's revenue was $97,735, an increase of 88.32% compared to the previous year's $51,897. Losses were -$13.10 million, 1602.5% more than in 2020.

Financial Statements

News

There is no news available yet.